About Index Trending news
Analyze
Top 50 Pricing
UniQure

UniQure

Work at UniQure? Add yourself to this profile

UniQure

uniQure is a world leader in the development of human gene based therapies for hemophilia B, acute intermittent porphyria, Parkinson’s disease and SanfilippoB.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Debt financing
$20,000,000
Private equity
$58,000,000
Employees

Team size

50+
Locations
Xconomy

Struggling UniQure Cuts Gene Therapies, Jobs, in Big Restructuring

Health Strategy
The Motley Fool , Xconomy

Here's Why uniQure N.V.'s Stock Spiked Today --